C4 Therapeutics, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2019
Total Assets: $118.3M
Liabilities Breakdown FY2019
Total Liabilities: $119.2M
Asset Breakdown
Total Assets: $118.3M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $90.5M | 76.6% |
| Accounts Receivable | $4.6M | 3.9% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $4.5M | 3.8% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $18.6M | 15.7% |
Liabilities Breakdown
Total Liabilities: $119.2M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $5.4M | 4.5% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $113.8M | 95.5% |